Management Team

Fred Parks, PhD
Fred Parks, PhD
Chief Executive Officer
Fred Parks has served as a Director of Nuvectra since March 2016 and was named CEO of Nuvectra in February 2019. He was most recently the President and Chief Executive Officer of Analogic Corporation, a medical imaging and aviation security company, from October 2016 to June 2018. Mr. Parks was also the Chief Executive Officer of Enovate Medical from July 2015 until October 2016. Prior to joining Enovate Medical, Mr. Parks served as Chief Executive Officer of NDS Surgical Imaging, LLC, from August 2011 to 2013 and as Chairman and Chief Executive Officer of Urologix, Inc., from May 2003 to February 2008. Prior to joining Urologix, Mr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, which is currently part of Philips Medical Systems. Through his career he has served as a director of Analogic Corporation, Enovate Medical, NDS Surgical Imaging, Urologix, EG&G, Inc. (now PerkinElmer), St. Jude Medical, and Steady State Imaging. Mr. Parks received a B.S. in Mechanical Engineering from University of Missouri-Rolla, an M.S. in Mechanical Engineering from the University of Arizona, and a Ph.D. in Mechanical Engineering from the University of Missouri-Columbia.
    Hanna
    Chris Hanna
    Vice President of Operations
    Chris Hanna joined Nuvectra in 2013 as Executive Director of Business Operations. As the current Vice President of Operations, he is responsible for strategic and functional responsibilities relating to supply chain, manufacturing, sales operations, warehousing, distribution, business analytics, purchasing, health policy/economics, reimbursement, and preauthorization functions. Mr. Hanna has more than 15 years of experience in neuromodulation in companies ranging from early stage to large corporate companies. Prior to the spinoff of Nuvectra, he led the development and execution of Nuvectra’s commercial infrastructure. Mr. Hanna has previously served in Director roles at DaVita and St. Jude Medical. Prior to that, he was Vice President of Strategy at Neuro Resource Group. Mr. Hanna has an M.B.A. from Southern Methodist University and a B.S. in Financial Management from Clemson University.
      Image
      Jennifer Kosharek
      Chief Financial Officer
      Jennifer Kosharek joined Nuvectra in January 2016 as Executive Director, Corporate Controller, and was appointed Chief Financial Officer in September 2019 after having served as interim Chief Financial Officer since May 2019. Ms. Kosharek leads the company’s external financial reporting, corporate accounting, corporate internal controls, shared services, payroll, and tax functions. Ms. Kosharek has held various finance and leadership positions and has more than 15 years of audit and accounting experience, including 8 years of public company accounting experience. Prior to joining Nuvectra, Ms. Kosharek was the Corporate Controller and subsequently served as the Chief Financial Officer and Vice President of Finance of Interphase Corporation from 2011 to 2015. Preceding her position at Interphase, Ms. Kosharek served as Senior Accountant – External Reporting and later as Accounting Manager at Sabre Holdings from 2008 to 2011. She began her career at Grant Thornton, LLP. Ms. Kosharek is a Certified Public Accountant and holds a Master’s of Public Accountancy from the University of Wisconsin-Whitewater.
        Alan Mock
        Alan Mock
        Vice President, Business Development
        Alan Mock joined the Nuvectra organization as part of QiG Group in April 2013 as Vice President of Commercialization and is responsible for developing and executing the commercialization plan for Nuvectra. Mr. Mock has more than 30 years of medical device experience in all aspects of sales and marketing. Prior to Nuvectra, Alan spent 15 years with Advanced Neuromodulation Systems (ANS) and, later, St. Jude Medical (SJM) as VP of Marketing for Chronic Pain Therapies and later as VP of Sales and Marketing for Neuro Therapies. During this time at ANS/SJM, he was responsible for the global commercialization of multiple product lines. Prior to ANS, Mr. Mock was VP of Sales and Marketing for Snowden-Pencer. Mr. Mock has a B.A. from the University of Florida.
          Bonnie Schmidt
          Bonnie Schmidt
          Vice President, Chief Human Resources Officer
          Bonnie Schmidt joined Nuvectra in 2015 as Director of Human Resources and is responsible for strategic and functional responsibilities across all HR disciplines. Ms. Schmidt has more than 20 years of human resources experience across numerous industries including medical devices, pharmaceutical commercialization, and healthcare analytics. Prior to joining Nuvectra, she served as the Director of HR for Sonexus Health, a Cardinal Health company. Preceding her position at Sonexus Health, Ms. Schmidt served as Senior HR Manager for St. Jude Medical. Ms. Schmidt has an M.B.A. in Healthcare Management from the University of Scranton and a B.A. from the University of Phoenix-Dallas.
            Image
            Ben Tranchina
            Chief Technical Operations Officer
            Ben Tranchina joined Nuvectra in August of 2018. He has more than 25 years of experience in technology business leadership in both early-stage and multi-national commercial companies and holds approximately 30 issued or pending patents relevant to neuromodulation. Prior to joining Nuvectra as Chief Technical Operations Officer, Mr. Tranchina served as the Chief Technology Officer for Neurotechnology Innovations Translator (NIT) LLC, a privately held company in Columbus, Ohio, which develops and commercializes neurotechnology solutions. During his tenure at NIT, Mr. Tranchina also served as CEO for NIT portfolio company Veressa Medical where he led the development of an innovative peripheral nerve stimulation system for the treatment of pelvic floor dysfunction and peripheral pain. Before that, Mr. Tranchina served in various leadership roles and as VP of Research and Development for ten years at St. Jude Medical’s (SJM) Neuromodulation Division and Advanced Neuromodulation Systems, Inc. (ANSI), a company acquired by St. Jude Medical, Inc., in 2005. During his time at SJM, Mr. Tranchina’s teams launched nine first-to-market products, and, as a result, he was awarded SJM’s Neuromodulation Inventor of the Year award. Mr. Tranchina holds a B.S. and a M.S. in Electrical Engineering from the University of Texas at Dallas, specializing in Microelectronic Circuits and Systems.